Interestingly, the application of NVP-BHG 712 under endothelial Ephrin-B2 depletion did not result in antimetastatic effects, which might be explained by the missing activation of tumor cell-bound EphB4 in the absence of endothelial Ephrin-B2. The gene discussed is EFNB2; the disease is neoplasm.